Joint Filing AgreementJoint Filing Agreement • November 13th, 2023 • Biotechnology Value Fund L P • Investment advice
The undersigned hereby agree that the Statement on Schedule 13G dated November 13, 2023 with respect to the Class A Common Shares of enGene Holdings, Inc., a Canada corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
